Degradation kinetics of antagonist [Arg6, D-Trp7,9, MePhe8]-substance P [6-11] in aqueous solutions. 1995

J L Reubsaet, and J H Beijnen, and A Bult, and O A van der Houwen, and J Teeuwsen, and E H Koster, and W J Underberg
Department of Pharmaceutical Analysis, Faculty of Pharmacy, Utrecht University, The Netherlands.

Antagonist [Arg6, D-Trp7,9, MePhe8]-substance P {6-11} was subjected to a systematic stability study in which kinetic parameters were obtained for the degradation of this hexapeptide under several well-defined conditions. The influences of pH, temperature, ionic strength, buffer concentration, and initial concentration of the peptide on the reaction rate constant, kobs, were investigated with a stability-indicating reversed-phase high-performance liquid chromatographic system. From the pH-log kobs degradation profile, obtained at 63 degrees C, it appears that antagonist [Arg6, D-Trp7,9, MePhe8]-substance P {6-11} shows its maximum stability around pH 4.2. The half-life at this pH and temperature is 150 days. In both the hydroxyl- and proton-catalyzed parts of the pH-log kobs degradation profile, the influence of temperature was investigated and Arrhenius plots were constructed. The activation energies in both parts were comparable; however, the frequency factor in the hydroxyl-catalyzed part was 3.3 x 10(4) times higher than in the proton-catalyzed part. Eyring analysis of the data reveals that in both acidic and alkaline media the overall degradation was endotherm (delta H++ as well as delta G++ positive between 273 and 373 degrees K) and the entropy was negative. Increasing ionic strengths in acidic media causes an increase in kobs, while in alkaline media the kobs decreases with increasing ionic strength. Increasing buffer concentrations of acetate, phosphate, and carbonate led to an increase of kobs values. Drug concentrations up to 1 mg/ml at pH 10.8 and constant temperature and ionic strength have no influence on the overall degradation rate. At higher concentrations, above 1 mg/ml, kobs decreases.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002021 Buffers A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer. Buffer
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D012996 Solutions The homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (the solvent), from which the dissolved substances can be recovered by physical processes. (From Grant & Hackh's Chemical Dictionary, 5th ed) Solution
D013373 Substance P An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses. Euler-Gaddum Substance P,Hypothalamic Substance P,SP(1-11),Euler Gaddum Substance P,Substance P, Euler-Gaddum,Substance P, Hypothalamic
D013696 Temperature The property of objects that determines the direction of heat flow when they are placed in direct thermal contact. The temperature is the energy of microscopic motions (vibrational and translational) of the particles of atoms. Temperatures
D014867 Water A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Hydrogen Oxide

Related Publications

J L Reubsaet, and J H Beijnen, and A Bult, and O A van der Houwen, and J Teeuwsen, and E H Koster, and W J Underberg
January 1998, Investigational new drugs,
J L Reubsaet, and J H Beijnen, and A Bult, and O A van der Houwen, and J Teeuwsen, and E H Koster, and W J Underberg
June 1994, Journal of pharmaceutical and biomedical analysis,
J L Reubsaet, and J H Beijnen, and A Bult, and O A van der Houwen, and J Teeuwsen, and E H Koster, and W J Underberg
March 1994, Journal of chromatography. B, Biomedical applications,
J L Reubsaet, and J H Beijnen, and A Bult, and O A van der Houwen, and J Teeuwsen, and E H Koster, and W J Underberg
January 1984, Die Pharmazie,
J L Reubsaet, and J H Beijnen, and A Bult, and O A van der Houwen, and J Teeuwsen, and E H Koster, and W J Underberg
January 2009, British journal of pharmacology,
J L Reubsaet, and J H Beijnen, and A Bult, and O A van der Houwen, and J Teeuwsen, and E H Koster, and W J Underberg
September 1983, British journal of pharmacology,
J L Reubsaet, and J H Beijnen, and A Bult, and O A van der Houwen, and J Teeuwsen, and E H Koster, and W J Underberg
January 2003, Methods in molecular medicine,
J L Reubsaet, and J H Beijnen, and A Bult, and O A van der Houwen, and J Teeuwsen, and E H Koster, and W J Underberg
June 2003, British journal of cancer,
J L Reubsaet, and J H Beijnen, and A Bult, and O A van der Houwen, and J Teeuwsen, and E H Koster, and W J Underberg
June 1999, British journal of cancer,
Copied contents to your clipboard!